Sloan Kettering Researchers Correct the Record by Revealing Company Ties
Mr. Morey also said of which a “patchwork” of disclosure requirements by different publications has complicated matters. “In many cases, researchers are right now disclosing above along with beyond what is usually asked for along with required, even when their disclosures have no connection to the research they conducted,” he said, adding of which Memorial Sloan Kettering has created a task force to establish its own standards. “This kind of is usually a massive, industrywide problem.”
In a statement, Dr. Thompson said his correction arose via the broader review. “I was no different,” he said. Of the more than 70 articles he published since arriving at the hospital in 2010, he said, “I identified one study in my review, of which I was a secondary author, of which I thought should be updated.”
Some of the omissions were extensive. In an updated disclosure, Dr. Wolchok, director of the Parker Institute for Cancer Immunotherapy at the hospital, outlined his ties to many companies, including receiving consulting fees, owning stock options or being a co-founder. The list of companies of which pay him range via major manufacturers like Bristol-Myers Squibb along with Merck, for whom he works as a paid for consultant, to start-ups like BeiGene, Apricity along with Adaptive Biotech, in which he reports owning stock options.
He corrected two articles within the journal Cancer Cell along using a third within the Journal of Clinical Investigation. Dr. Wolchok is usually a widely regarded expert in immunotherapy, having treated some of the first patients using a drug based on the work of Dr. James P. Allison, who along with Tasuku Honjo won This kind of year’s Nobel Prize for Medicine.
some other Memorial Sloan Kettering researchers on Dr. Wolchok’s papers also updated their interactions with industry, including Dr. Matthew D. Hellmann, Dr. Taha Merghoub along with Dr. Michael A. Postow.
“Although the below additional disclosures are not directly relevant to the published work, the authors put them forward within the spirit of full transparency,” one correction said. “The authors apologize for any inconvenience.”